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Abstract
Background: Calnexin, together with calreticulin, constitute the calnexin/calreticulin cycle. Calnexin is a type I endoplasmic
reticulum integral membrane protein and molecular chaperone responsible for the folding and quality control of newly-
synthesized (glyco)proteins. The endoplasmic reticulum luminal domain of calnexin is responsible for lectin-like activity and
interaction with nascent polypeptide chains. The role of the C-terminal, cytoplasmic portion of calnexin is not clear.
Methodology/Principal Findings: Using yeast two hybrid screen and immunoprecipitation techniques, we showed that the
Src homology 3-domain growth factor receptor-bound 2-like (Endophilin) interacting protein 1 (SGIP1), a neuronal specific
regulator of endocytosis, forms complexes with the C-terminal cytoplasmic domain of calnexin. The calnexin cytoplasmic C-
tail interacts with SGIP1 C-terminal domains containing the adaptor complexes medium subunit (Adap-Comp-Sub) region.
Calnexin-deficient cells have enhanced clathrin-dependent endocytosis in neuronal cells and mouse neuronal system. This is
reversed by expression of full length calnexin or calnexin C-tail.
Conclusions/Significance: We show that the effects of SGIP1 and calnexin C-tail on clathrin-dependent endocytosis are due
to modulation of the internalization of the receptor-ligand complexes. Enhanced clathrin-dependent endocytosis in the
absence of calnexin may contribute to the neurological phenotype of calnexin-deficient mice.
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Introduction
Calnexin is a type I endoplasmic reticulum (ER) integral
membrane protein with a single transmembrane helix followed by
a cytoplasmic negatively charged C-terminal tail [1,2]. The ER
luminal domain of calnexin is responsible for lectin-like activity
and interaction with nascent polypeptide chains [3,4]. Calnexin,
together with calreticulin, constitute the calnexin/calreticulin cycle
responsible for the folding and quality control of newly-synthesized
(glyco)proteins [5,6]. Calnexin has also been implicated in
influencing Ca
2+ regulation [1,7,8,9], cell-cell adhesion [10],
phagocytosis [11], and cell sensitivity to apoptosis [12,13]. X-ray
crystallography studies have identified the ER luminal domain of
calnexin as forming a globular b-sandwich containing a glucose
binding site with a proline-rich portion of the protein forming an
extended arm structure [14], a docking site for oxidoreductase
ERp57 [15,16,17,18]. The C-terminal portion of calnexin extends
86 amino acid residues but its significance to calnexin function is
not clear. This C-terminal domain of calnexin undergoes protein
kinase-dependent phosphorylation [19,20] and this modification
may play a role in the chaperon function of the protein [20].
Endocytosis is a process by which cells internalize materials into
the cell by engulfing them with plasma membrane. One sub-type
of endocytosis, clathrin-dependent endocytosis, is responsible for
the internalization of specific molecules into the cell including:
pathogens, nutrients, antigens, growth factors and receptors
[21,22]. During clathrin-dependent endocytosis, molecules are
taken into the cell by specific receptor-ligand interactions. Integral
membrane proteins bind to cytosolic adaptors (AP-2), which form
a link to the cytoplasmic clathrin lattice. Accessory proteins, such
as Eps15 and AP180, have the ability to affect the process of
clathrin mediated endocytosis by facilitating the assembly of
clathrin-coated pits [23,24,25]. Although single-cell organisms use
endocytosis as the means to obtain nourishment, higher organisms
have adapted endocytosis for specialized functions. These
functions include modulating interactions between signaling
molecules and their receptors and providing a localized environ-
ment where signaling takes place [26,27]. Endocytosis is especially
vital for the neuronal system [28]. These processes allows retrieved
fused vesicles to refill the vesicle pool allowing sustained synaptic
transmission and maintenance of terminal nerve size [29]; specific
substances to cross the blood-brain barrier and enter the central
nervous system [30]; and internalizes receptor-ligand complexes to
nerve terminals for their intracellular signaling [31]. Recent
studies indicate that Src homology 3-domain growth factor
receptor-bound 2-like (Endophilin) interacting protein 1 (SGIP1)
may play a role in modulation of endocytotic activity in neuronal
cells [32,35].
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The carboxyl-terminal cytoplasmic tail of calnexin
interacts with SGIP1
Calnexin is composed of structural and functional domains [33].
While the ER luminal region is responsible for the chaperone
function of the protein, the transmembrane domain anchors the
protein to the membrane and the C-terminal tail extends to the
cytoplasmic compartment. To examine the functional importance
of cytoplasmic tail of calnexin we carried out the yeast two hybrid
screening method to identify proteins interacting with the C-
terminal cytoplasmic domain of calnexin (designated C-tail)
encompassing the last 88 amino acids (C
504-E
591) of the protein.
Because calnexin-deficient mice have neurological disorders
[34,44], we used a mouse brain Matchmaker cDNA library
(638841, Clontech, USA) to identify calnexin interacting proteins
in a neuronal system. Screening of the library resulted in the
identification of 9 positive clones. Three of these clones encoded
the C-terminal region of SGIP1 (Src homology 3-domain growth
factor receptor-bound 2-like (Endophilin) interacting protein 1)
[32,35]. The longest cDNA fragment of SGIP1 identified in the
screen was 537 nucleotides and encoded the last 179 amino acids
of the protein. This C-terminal region of SGIP1 contains the
domain referred to as the adaptor complexes medium subunit
(Adap-Comp-Sub) (Fig. 1A). This adaptor complex may couple
clathrin lattices with membrane proteins and play a role in
clathrin-dependent endocytosis (http://pfam.sanger.ac.uk/famil
y?id=Adap_comp_sub).
To test for direct interactions between the calnexin C-tail
domain and SGIP1, we carried out immunoprecipitation analysis.
N1E-115 neuroblastoma cells were transfected with expression
vectors encoding GFP-SGIP1 or GFP control followed by cell
lyses, immunoprecipitation with anti-GFP antibodies and Western
blot analysis with anti-calnexin antibodies. Figure 1B (lane 5) shows
that calnexin was present in GFP-SGIP1 immunoprecipitate
indicating that these two proteins interacted. As expected, there
was no immunoreactive calnexin in GFP expressing cells (Fig. 1B,
line 6). Since SGIP1 is predominantly expressed in the brain,
especially in cerebellum ([35], http://www.ncbi.nlm.nih.gov/
UniGene/ESTProfileViewer.cgi?uglist=Mm.238094), we used
cerebellum extracts to test for endogenous SGIP1-calnexin
complexes. Anti-SGIP1 antibodies immunoprecipitated SGIP1
from cerebellum homogenate (Fig. 1C, lane 2), and the complexes
contained immunoreactive calnexin (Fig. 1C, lane 5). Since SGIP1
antibodies were generated against His-tagged recombinant SGIP1
we also employed anti-His-tag antibodies as a negative control
(Fig. 1C, lanes 3 and 6). We concluded that calnexin interacted with
SGIP1 in vivo in N1E-115 cells and in cerebellum. Next we carried
out immunolocalization analysis in N1E-115 cells expressing
recombinant GFP-SGIP1. Figure 1D shows that GFP-SGIP1 and
calnexin co-localized to the ER-like network. Quantitative analysis
for SGIP1-calnexin colocalization showed that 66.78% (Std.
Error=4.22%, n=20) of GFP-colocalized with calnexin, support-
ing the biochemical and immunological results that the two
proteins form complexes. The RT-PCR analysis showed that
SGIP1 is predominantly expressed in brain, spinal cord and
cerebellum (Fig. 1E). This is in agreement with earlier studies
[32,35] indicating that there is a high expression of the protein in
neuronal tissues. Since calnexin-deficient mice develop neuropa-
thies, we examined whether calnexin affects expression of SGIP1.
Figures 1E and F show that expression of SGIP1 mRNA and
protein was not affected in the absence of calnexin.
To carry out molecular analysis of the interaction between
calnexin and SGIP1, we isolated cDNA encoding mouse SGPI1
from the mouse brain Matchmaker cDNA library followed by
nucleotide sequence analysis of the clone. Nucleotide and amino
acid sequences of this mouse variant of SGIP1 (2481 bp, encoding
a protein of 826 amino acids) differed from the rat SGIP1a [35]
and the mouse SGIP1 released from NCBI (Fig. S1). Important
difference between the clones was that the region encompassing
amino acid residues G35-Q62 in rat SGIP1a was not present in
mouse SGIP1 (Fig. S1). Comparison of the protein sequence of
mouse SGIP1 isolated in our laboratory with that available at the
NCBI revealed two additional differences. The mouse clone
isolated in this study had an L in position 295 versus an F in the
NCBI sequence and a P in position 355 versus a T in the NCBI
sequence (Fig. S1). We concluded that the calnexin C-terminal tail
interacts with SGIP1, a newly identified neuronal version.
MP domain of SGIP1 binds phospholipids and it may be
involved in interactions with Esp15 [32], an adaptor protein of
clathrin-mediate endocytosis [22]. The central, proline-rich
domain of SGIP1 may form complexes with endophilin-3 [35],
an important regulator of clathrin-mediated endocytosis and
synaptic vesicles recycling [21,22]. Next we mapped the SGIP1
domains interacting with the calnexin C-tail. To do this we
generated cDNA encoding three different regions of SGIP1
(Fig. 1G): the N-terminal domain membrane phospholipid-binding
domain (MP, amino acid residues 1–239) and a proline rich region
(Pro-Rich, amino acid residues 239–653), and a domain
containing the adaptor complexes medium subunit (Adap-
Comp-Sub, amino acid residues 647–826), and cloned into the
pGADT7 vector to test their interaction with the calnexin C-tail in
the yeast-two-hybrid system. Yeast-two-hybrid analysis revealed
that calnexin-C-tail interacted with the C-terminal region of
SGIP1 (Adap-Comp-Sub domain, amino acid residues 647–826,
Fig. 1G). We concluded that interaction between the calnexin C-
domain and SGIP1 maps to the Adap-Comp-Sub domain of
SGIP1.
Increased clathrin-dependent endocytosis in the absence
of calnexin
Considering that SGIP1 is a neuronal endocytotic protein
interacting with adaptor proteins involved in clathrin-dependent
endocytosis [32,35] and that the SGIP1a has been implicated to
play a role in endocytosis in neuronal cells [32], we tested whether
calnexin may play any role in neuronal endocytosis. First, we
examined whether GFP-SGIP1 affects uptake of transferrin in
N1E-115 cells. Transferrin has been commonly used as an
indicator of clathrin-dependent endocytosis [36]. N1E-115 cells
were transfected with either GFP-SGIP1 or GFP expression
vectors, incubated with Alexa-transferrin, fixed and examined by
confocal microscopy. As expected, expression of GFP in N1E-115
cells did not have any effect on transferrin uptake (Fig. 2A, left
panel). In contrast, GFP-SGIP1 expressing cells had significantly
inhibited transferrin uptake (Fig. 2A, right panel).
Second, we asked whether clathrin-dependent endocytosis
might also be affected in the absence of calnexin. Cerebellar
granule cells were isolated from of 7 day old wild-type and
calnexin-deficient mice. A mixed granule cell culture was
established containing wild-type and calnexin-deficient cells. Cells
were cultured for 4 days in neurobasal plus medium followed by
the transferrin uptake assay. Wild-type cells were identified by a
positive staining with anti-calnexin antibodies (Fig. 2B, left panel).
Analysis of transferrin uptake of mixed cultures showed signifi-
cantly increased transferrin uptake in all calnexin-deficient cells
examined (n=80) (Fig. 2B, compare middle and left panels)
indicating that there was increased clathrin-dependent endocytosis
in granule cells isolated from calnexin-deficient mice. In addition
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PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21678Figure 1. Calnexin interacts with SGIP1. (A) A schematic representation of full length SGIP1. The N-terminal domain of SGIP1 (amino acid
residues 1–239) represents a membrane phospholipid-binding domain (MP, dark green); middle domain (amino acid residues 239–653) contains a
proline-rich region (Pro-Rich, light green); the C-terminal region contains an adaptor-complex-subunit (Adap-Comp-Sub, red). (B) N1E-115 cells were
transfected with GFP-SGIP1 or GFP expression vectors and lysed cells were subjected to immunoprecipitation with anti-GFP. Calnexin was identified
by Western blot (WB) analysis of imunoprecipitates probed with anti-calnexin antibodies (lanes 3–6). Lane 1, Western blot analysis of N1E-115 cells
expressing GFP-SGIP1; lane 2, Western blot analysis of N1E-115 cells expressing GFP; lane 3, identification of calnexin in N1E-115 cells expressing GFP-
SGIP1; lane 4, identification of calnexin in N1E-115 cells expressing GFP; lane 5, lysate from N1E-115 cells expressing GFP-SGIP1 were
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calnexin-deficient fibroblasts (Fig. 2C and 2D) indicating that
there was significant increase in endocytic activities in cells lacking
calnexin.
Next we carried out electron microscopy analysis of cerebella
from 7 day old wild type and calnexin-deficient mice to examine
whether there was increased clathrin-dependent endocytosis in
mice in the absence of calnexin mice. Figure 2E shows that
calnexin-deficient mice had significantly increased number of
synaptic vesicles when compared to wild-type cerebellum. The
numbers of synaptic vesicle were quantitated using 16 wild-type
neurons and 10 calnexin-deficient neurons. The mean number of
clathirn coated vesicles for wild-type and calnexin-deficient
neurons was 18.661.5 and 37.363.6, respectively (Fig. 2F). We
concluded that calnexin deficiency leads to increased endocytotic
activity in cultured cells and mouse neuronal system.
Next, we examined whether expression of full length calnexin in
cnx
2/2 cells will reduce the endocytotic activities seen in calnexin-
deficient cells. We isolated granule cells from wild-type and
calnexin-deficient cerebellum, followed by expression of recombi-
nant GFP, GFP-SGIP1, full length calnexin or calnexin C-tail.
Expression of GFP alone in wild-type and calnexin-deficient cells
had no effects on transferrin uptake which remained high as
observed for calnexin-deficient cells (Fig. 3A, left panel). As
expected, expression of SGIP1 had an inhibitory effect on
endocytosis in granule cells independent of the presence (wild-
type) or absence (cnx
2/2) of calnexin (Fig. 3A, right panel). Figure 3B
(left panel) shows that both wild-type and calnexin-deficient cells
transfected with calnexin expression vector and expressing full-
length calnexin had reduced transferrin uptake compared to
control, non-transfected cells. Transferrin uptake in these cells was
similar to that observed for wild-type cells. Combined results
presented in Figures 2 and 3 indicate that that calnexin and SGIP1
affected endocytotic activities of cerebella granule cells. Since we
observed that the C-terminal domain of calnexin (C-tail)
interacted with SGIP1, we asked whether the C-tail of calnexin
alone would have any effect on transferrin uptake in granule cells.
Figure 3B (right panel) shows that expression of recombinant, GFP
tagged C-tail of calnexin resulted in significantly reduced
endocytosis in calnexin-deficient and wild-type granule cells. We
also tested for the role of SGIP1 and calnexin C-tail in endocytosis
in the N1E-115 neuronal cell line. Figure 3C shows, that similar to
granule cells, expression of SGIP1 and calnexin C-tail in N1E-115
cells resulted in reduced transferrin uptake indicative of reduced
endocytosis.
Next, we tested whether epidermal growth factor (EGF) as
another marker for clathrin-dependent endocytosis was affected by
calnexin in neuronal cells. N1E-115 neuronal cells were
transfected with expression vectors encoding GFP-calnexin C-tail,
or GFP-SGIP1 followed by analysis of EGF induced endocytosis.
Figure 4 shows that expression of calnexin C-tail or SGIP1 in
N1E-115 cells significantly decreased Alexa-EGF uptake in all
examined cells that expressed GFP fusion proteins (n=90)
indicating that calnexin C-tail and SGIP1 inhibited clathrin-
dependent endocytosis. These findings indicate that calnexin C-
tail is an important factor involved in clathrin-dependent
endocytosis. It is likely that the calnexin C-tail exerts its effects
on endocytosis by interacting with SGIP1, a protein that forms
complexes with endophilin-3 [35], AP-2 complex, Eps15 and
phospholipids [32] to affect clathrin-dependent endocytosis.
Calnexin C-tail affects endocytosis at ligand
internalization
Clathrin-dependent endocytosis is a temperature sensitive
process. At physiological temperature (37uC) there is rapid
clathrin-dependent endocytosis, whereas at 16uC, endocytosis is
slow and permissive for receptor-ligand internalization and does
not support recycling or degradation [37]. In contrast, at 0–4uC,
internalization of the ligand is inhibited without any effect on
ligand binding to the receptor [37]. We took advantage of these
temperature-dependent effects on endocytosis to examine which
phase of clathrin-dependent endocytosis was affected by SGIP1
and the calnexin C-tail. To do this, N1E-115 cells expressing
recombinant GFP-SGIP1 or GFP calnexin C-tail were incubated
at different temperatures (4uCo r1 6 uC) followed by analysis of
Alexa-transferrin uptake. Transferrin ligand binding to cells
expressing either GFP-SGIP1 or GFP-calnexin C-tail was not
affected at 0uC (Fig. 5A). However, there was no internalization of
the ligand under these conditions in all cells that expressed GFP
fusion proteins (n=90) (Fig. 5A). In contrast, at 16uC, all cells
expressing recombinant GFP-SGIP1 or GFP-calnexin C-tail
(n=90) had reduced Alexa-transferrin uptake compared to GFP
expressing cells or non-transfected control cells (Fig. 5B). Since
receptor recycling and degradation are inhibited at 16uC [37], we
concluded that SGIP1 and the calnexin C-tail affected the ligand-
internalization step during clathrin-dependent endocytosis. West-
ern blot analysis revealed that expression of transferrin and EGF
receptors was not affected in cells expressing calnexin C-tail
(Fig. 5C). And there’s no differences between wild type (wt) and
calnexin-deficient (cnx
2/2) cerebella on Transferrin or EGF
receptors expression level either (Fig. 5D). Next, we carried out
FACS analysis to quantify the transferrin receptor levels in wild-
type and cnx
2/2 cell lines. Figure 5E shows that the level of cell
surface expression of transferrin receptor was the same in wild-
type and and cnx
2/2 cell lines. These results supported a notion
that the effects of SGIP1 and calnexin C-tail on clathrin-
dependent endocytosis were not due to a reduced level of
immunoprecipitated with anti-GFP antibodies followed by Western blot analysis with anti-calnexin antibodies; lane 6, lysate from N1E-115 cells
expressing GFP were immunoprecipitated with anti-GFP antibodies followed by Western blot analysis with anti-calnexin antibodies. (C)
Immunoprecipitation of SGIP1-calnexin complexes from mouse cerebellum. Homogenate from wild-type mouse cerebellum was incubated with anti-
SGIP1 antibodies or anti-His-tag antibodies followed by Western blot analysis with either anti-SGIP1 antibodies (lanes 1–3) or anti-calnexin antibodies
(lanes 4–6). Lanes 1 and 4, cerebellum homogenate; lanes 2 and 5, immunoprecipitated with anti-SGIP1 antibodies; lanes 3 and 6,
immunoprecipitation with anti-His-tag antibodies. CNX, calnexin. (D) Immunolocalization of calnexin and GFP-SGIP1 in N1E-115 cells. N1E-115
cells were transfected with pEGFP-SGIP1 expression vector followed by confocal analysis of intracellular localization of GFP-SGIP1 and calnexin as
described under ‘‘Experimental Procedures’’. Scale bar=17 mm. (E) mRNA were isolated from liver, brain, spinal cord and cerebellum of wild-type (wt)
and calnexin-deficient (cnx
2/2) mice followed by RT-PCR with DNA primers specific for SGIP1 (SGIP1) or tubulin (tubulin) as described under
‘‘Experimental Procedures’’. (F) Western blot analysis of protein extracts isolated from wild-type (wt) and calnexin-deficient (cnx
2/2) granule cells was
carried out with anti-SGIP1-antibodies as described under ‘‘Experimental Procedures’’. (G) Yeast cells were transformed with pGBKT7 vector
containing cDNA encoding calnexin C-tail (CNX C-tail) and pGADT7 vector or pGADT7 vector containing cDNA encoding SGIP1 or SGIP1 domains as
depicted in the Figure. Yeast serial dilution-culture (10
21,10
24) on SD/-Leu/-Trp plate shows both pGBKT7 and pGADT7 vectors were transformed
into the AH109 strain. Yeast culture on SD/-Leu/-Trp/-His/-Ade shows yeast-two-hybrid interaction and activation of the reporter gene. Filter lift
assays indicates interactions between the calnexin C-tail and SGIP1 and specifically the SGIP1 C-terminal Adap-Comp-Sub domain.
doi:10.1371/journal.pone.0021678.g001
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e21678Figure 2. Increased endocytosis in the absence of calnexin. (A) Alexa647-transferrin (Alexa-Tfn) uptake in N1E-115 cells expressing GFP (left
panels) or GFP-SGIP1 (right panels). Non-transfected N1E-115 cells or N1E-115 cells expressing GFP (left panels) show significant uptake of Alexa-Tfn. In
contrast cells expressing GFP-SGIP1 (right panels) have significantly inhibited Alexa-Tfn uptake. The asterisks indicate the location of cells expressing
GFP or GFP-SGIP1. Scale bar=10 mm. (B) Alexa-Tfn endocytosis in a mixed culture of granule cells isolated from wild-type and cnx
2/2 mice. Left panel,
immunostaining with anti-calnexin antibodies. Middle panel, granule cells were incubated with Alexa-Tfn at 37uC for 10 min followed by confocal
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internalization of the receptor-ligand complexes.
Although many fundamental eukaryotic trafficking mechanisms
are conserved in neurons, they have evolved distinct modes of
trafficking to accommodate their unique morphology and function
[37]. Furthermore, different endocytotic mechanisms specific for
different surface molecules and cellular domains exist in neurons
[28]. Specificity of calnexin to affect clathrin-dependent endocy-
tosis in the nervous system is remarkable and likely dictated by
calnexin interaction with SGIP1. The N1E-115 neuronal cell line
has very low SGIP1 expression and does not express Eps15 or
AP180, and full length calnexin does not affect endocytosis in these
cells (Fig. S2). In sharp contrast, cultured granule cells expressing
large quantities of SGIP1, are highly sensitive to calnexin-
dependent effect on endocytosis (Fig. 2B and Fig. 3B). Neurons
are specialized types of cells, and the exocytosis-endocytosis
balance is vital for neurons to play its normal functions and to
survive. In addition, there are specific protein components
required for clathrin-dependent endocytosis in neurons, for
example, neuron-specific variants of a- and b-adaptin chains have
been identified [38]. We found that SGIP1 is primarily expressed
in the neuronal system, and other essential neuronal endocytic
factors, AP180 and Eps15, were also more abundant in the
cerebellum than in neuronal cell lines (Fig. S2). Association of
specific endocytosis related factors with nerve terminal-derived
vesicles suggests a functional specialization of nerve terminal to
adapt to the specific requirements of synaptic vesicle recycling
[39]. The specific intra- and intercellular environment of the
neuron may provide factors that cooperate with full length
calnexin to decrease clathrin-dependent endocytosis.
One of the best described functions of calnexin is its role as a
molecular chaperone [40]. Little information is available about the
structure and function of the cytoplasmic calnexin C-tail as the
majority of studies on calnexin has focused on its ER luminal
lectin-like chaperon domain [41]. Here we showed that the
calnexin C-tail is a potent inhibitor of endocytosis in neuronal cells
indicating a functional specialization of calnexin domains. The C-
terminal region of calnexin binds Ca
2+ and can be phosphorylated
by specific protein kinases and this enhances calnexin’s interac-
tions with ribosomes [19,20]. Ca
2+ may affect endocytosis by the
neuronal system by arresting synaptic vesicle movement or
increasing synaptic vesicle size [42,43]. Absence of calnexin results
in a severe neurological phenotype in mice manifested by impaired
gait, reduced lower limb function [34,44] and inhibited nerve
conductive velocity due to impaired myelination of the peripheral
and central nervous system [34]. Increased endocytosis in the
nervous system in the absence of calnexin as described in this study
may also, at least in part, contribute to the phenotype of calnexin-
deficient mice. For example, endocytosis and postendocytic sorting
of neurotransmitter receptors have emerged as critical mechanisms
responsible for various forms of synaptic plasticity [28]. Calnexin
may affect these critical pathways and impact synaptic plasticity
and consequently the function of the nervous system. This, at least
in part, might be mediated by C-terminal cytoplasmic domain of
calnexin.
Materials and Methods
Plasmids, yeast two-hybrid assays and RT-PCR
The mouse brain Matchmaker cDNA library in pACT2
(Clontech, 638841) was transformed into yeast strain AH109.
The library was screened for interacting proteins with the C-
terminal cytoplasmic region of calnexin (C-tail) corresponding to
the last 87 amino acids (C504-E591). cDNA encoding the C-tail of
calnexin was obtained by PCR amplification of a mouse calnexin
template cDNA using the following primers: the 59 forward primer
59-GGA ATT CCA TAT GTG TTC TGG AAA GAA AC-39
and the 39 reverse primer 59-AAG GTT CTG CAG TCA CTC
TCT TCG TGG CT-39. The PCR product was cloned in frame
with the GAL4 DNA-binding domain at NdeI and PstI restriction
sites to generate the clone pGBKT7-CNX-C. Screening of the
mouse library was carried out as recommended by the
manufacturer (Clontech). Plasmid DNA from positive clones was
isolated and used as template for amplification of the insert in the
library vector by the AD (activating domain) sequencing primer
and T7 Y2H sequencing primer.
For synthesis of cDNA encoding SGIP1, RNA was isolated from
liver, brain, spinal cord and cerebellum using TRIzol (Invitrogen).
For PCR-driven synthesis of cDNA encoding SGIP1 the following
primers were used: forward primer 59-CGC GGA TCC GAA
TGA TGG AAG GAC TGA AA-39 and reverse primer 59-CCG
CTC GAG TTA GTT ATC TGC CAA GTA CT-39. For RT-
PCR the following primers were used: for SGIP1 forward primer
59-AAT GTG GAC ATG CTC AA ATA-39 and reverse 59-TTA
GTT ATC TGC CAA GTA CT-39; for tubulin forward 59-CCG
GAC AGT GTG GCA ACC AGA TCG G-39, and reverse 59-
TGG CCA AAA GGA CCT GAG CGA ACG G-39.
Cell culture, immunoprecipitation, Western blot and
FACS analyses
Cerebellum was isolated from a 7-day-old mouse, cut into small
pieces and digested in trypsin for 12 min at 37uC. Tissues was
washed twice with PBS and spun down at 350 xg for 5 min to
collect dissociated cells. Cells were suspended in neurobasal
medium (Gibco) with 2% B-27, 80 mg/L D-glucose, 20 mMl -
glutamine, 1% Penicillin/Streptomycin and 20 mM KCl, and
then passed through a 40 mm filter. Granule cells (5610
6 freshly
isolated granule cells) were combined with 2 mg plasmid and
100 mL mouse neuron nucleofector (Amaxa). Transfection of cell
lines with expression vectors was carried out using the lipofecta-
mine 2000 system (Invitrogen) according to the manufacturer’s
recommendation.
For immunoprecipitation, N1E-115 neuronal cells (CRL 2263
from the American Type Culture Collection) were treated for
15 min on ice with RIPA buffer containing 50 mM Tris, pH 7.4,
150 mM NaCl, 1% NP-40 (nonyl phenoxylpolyethoxylethanol),
0.25% sodium deoxycholate and 1 mM EDTA. For cerebellum
immunoprecipitation, cerebellum was grinded into powder in
liquid nitrogen followed by incubation with a RIPA buffer.
Solubilized cells or cerebellum tissue power was spun down at
16,000 xg for 10 min at 4uC. Sample was pre-cleared by
microscopy. Right panel, a merge of both images. The asterisks indicate the location of calnexin-deficient cells. Scale bar=17 mM. (C) Confocal images
of wild-type (wt) and calnexin-deficient (cnx
2/2) fibroblasts incubated with Alexa-Tfn at 37uC for 10 min. Calnexin was identified with anti-calnexin
antibodies. Scale bar=10 mm. (D) Quantitative analysis of HRP-Tfn uptake of wild-type (wt) and calnexin-deficient (cnx
2/2) fibroblasts. HRP-Tfn was
incubated with fibroblasts at 37uC for the time indicated in the Figure. (E) Electron microscope analysis of clathrin-coated synaptic vesicles in neurons
of wild-type (wt) and calnexin-deficient (cnx
2/2) cerebellum. Scale bar=0.2 mm. (F) Quantitative analysis of synaptic vesicles in neurons of wild-type
(wt) and calnexin-deficient (cnx
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30 min. Antibodies were added to pre-cleared sample and
incubated at 4uC for 3 hrs on an orbital rocker. Thirty mLo f
Protein A/G bead solution was added followed by overnight
incubation at 4uC. Beads were spun down at 1,000 xg for 3 min,
washed 5 times with ice cold PBS and re-suspend in SDS-PAGE
sample buffer. Proteins were separated by SDS-PAGE (7.5%
acrylamide) followed by Western blot analysis with goat anti-GFP
(1:10,000, Abcam), rabbit anti-calreticulin (1:1,000, Abcam),
rabbit anti-calnexin (1:1,000, Stressgen Bioreagents), rabbit anti-
transferrin receptor (1:200, Santa Cruz Biotechnology), rabbit
anti-EGFR (epidermal growth factor receptor) (1:500, Santa Cruz
Biotechnology), mouse anti-AP180 (1:200, Sigma) and mouse anti-
Eps15 (1:200, BD Biosciences), rabbit anti-SGIP1 (1:200,
homemade). For SGIP1 antibody generating, we cloned coding
sequence of last 159 amino acids from mouse and it was clone in
frame with 66His Tag at XhoI and KpnI restriction sites of pBAD/
gIII-A vector to express SGIP1 C-terminus-His Tag peptide in E.
coli. strain Rosetta BL21 (Novagen, Germany). SGIP1 C-terminus-
His was purified by Ni
2+-affinity chromatography. New Zealand
white rabbits (2,2.5 kg) was injected with 0.5 mg SGIP1 CT-His
mixed with 0.5 mL Freund’s adjuvant (Sigma, F-5506) three times
before collect blood to harvest antiserum. Before injection, 2 mL
bleed was taken from the rabbit for pre-bleed serum. Protein
concentration was estimated using a BioRad DC Protein assay
[45]. All animal experimental procedures were approved by the
Animal Welfare Program at the Research Ethics Office, the
Health Sciences Animal Policy and Welfare Committee (ID 069),
University of Alberta and conformed to the guidelines set forth by
the Canadian Council on Animal Care.
FACS analysis was carried out using BD FACScan single laser
flow cytometry (BD Bioscience) equipped with a 488-nm filter.
Data were collected from 10,000 cells and analyzed using
CellQuest software. Cells at 80–90% confluence were harvested
by scraping into PBS, re-suspended in 100 mL of 0.1%
formaldehyde in PBS, and incubated for 30 min with the anti-
transferrin receptor antibodies (eBioscience, 11–0711). Cells
stained with FITC alone were used as negative control.
Endocytosis analysis
Prior to endocytosis analysis cells were starved in serum-free
medium for 1 hr followed by incubation with 25 mg/mL
transferrin (Tfn) Alexa-Fluor 647 and 100 ng/mL EGF Alexa-
Fluor 647 at 37uC for 10 min. Ligand uptake was terminated by
placing cells on ice. Cells were rinsed in PBS and fixed in 3.7%
paraformaldehyde. Internalized ligand was visualized using
confocal microscopy. For Tfn endocytosis quantification, cells
were first incubated with 25 mg/mL HRP-Tfn on ice for 60 min,
and then shifted to 37uC for 2 min, 5 min or 10 min. Cells were
washed twice with cold PBS/30 mM glycine at pH 2.7, twice with
ice cold PBS and lysed with 1% Triton X-100 in PBS. Cells were
lysed and 200 mL lysate aliquots were missed with 1 mL
SIGMAFAST
TM OPD (o-phenylenediamine dihydrochloride)
solution (Sigma) for HRP-OPD analysis to reveal HRP-Tfn
uptake. The HRP-OPD color developing reaction was stopped by
addition of 1/4 volume of 3 M H2SO4 followed by OD492
measurements.
Immunofluorescence, confocal and electron microscopy
Immunofluorescence and confocal microscopy was carried out
as described previously [46]. Both rabbit anti-calnexin and goat
anti-rabbit Alexa secondary antibody were diluted as 1:200 in PBS
plus 2% milk powder and 0.1% saponin. All confocal microscopy
images were taken under 606objectives.
For electron microscopy analysis, 7-day old mice were
euthanized by decapitation and their cerebella were taken.
Primary fixation was carried out at 4uC for 4 hrs in a freshly
prepared solution of 2.5% glutaraldehyde and 2% paraformalde-
hyde in 100 mM cacodylate buffer pH 7.2, and then fixed in 2.5%
glutaraldehyde, 100 mM sodium cacodylate pH 7.0 [47]. Samples
were processed for electron microscopy and examined with a
Hitachi Transmission Electron Microscope H-7000.
Figure 3. Calnexin C-tail inhibits transferrin uptake. (A) Alexa647-transferrin (Alex-Tfn) uptake in wild-type (wt) and calnexin-deficient (cnx
2/2)
granule cells expressing GFP (left panel) or GFP-SGIP1 (right panel). Scale bar=5 mm. (B) Alexa-Tfn endocytosis in wild-type (wt) and calnexin-deficient
(cnx
2/2) granule cells expressing GFP tagged full-length calnexin (left panel) or GFP tagged C-tail of calnexin (CNX C-Tail) (right panel). Granule cells
were incubated with Alexa-Tfn at 37uC for 10 min as described under ‘‘Experimental Procedures’’. Scale bar=5 mm. (C) N1E-115 neuronal cells were
transfected with expression vectors encoding GFP, GFP tagged SGIP1 (SGIP1) or calnexin C-tail (CNX C-Tail) followed by Alexa-Tfn uptake analysis.
N1E-115 cells expressing GFP were used as control. The asterisks indicate cells expressing recombinant GFP-SGIP1 or recombinant calnexin C-tail
(CNX C-Tail). Scale bar=10 mm.
doi:10.1371/journal.pone.0021678.g003
Figure 4. Calnexin affects clathrin-dependent endocytosis. N1E-
115 cells were transfected with expression vectors encoding GFP, GFP
tagged SGIP1 (SGIP1) or calnexin C-tail (CNX C-Tail) and incubated with
Alexa647-Epidermal Growth Factor (Alexa-EGF), a ligand-induced
clathrin-dependent endocytosis marker at 37uC for 10 min. Scale
bar=17 mm.
doi:10.1371/journal.pone.0021678.g004
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Figure S1 Comparison of amino acid sequence of
different SGIP1 isoforms. Protein sequence alignment for
mouse SGIP1 sequence gotten from this study (SGIP1), mouse
SGIP1 sequence release from NCBI (SGIP1-NCBI; GenBank:
CAM14981) and rat SGIP1 alpha sequence shown in ref. 32
(SGIP1-alpha; GenBank:AB262964).
(EPS)
Figure S2 Expression of endocytic proteins in the
absence of calnexin. (A) Expression of full length calnexin
did not inhibit endocytosis in N1E-115 cells. Alexa 647-transferrin
(Alex-Tfn) uptake in N1E-115 cells expressing GFP (upper panel)o r
full length calnexin (CNX, lower panel). (B) Western blot analysis of
extracts from N1E-115 cell line and cerebellum was carried out
with anti-calnexin, anti-SGIP1, anti-Eps15 and anti-AP180
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